Photo via The Straits Times

WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight

Read the original at The Straits Times ↗
Cite

The Straits Times. (2026, October 7). WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight. The Straits Times. https://www.straitstimes.com/world/who-endorses-lifestyle-changes-over-glp-1-drugs-in-child-obesity-fight

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Straits Times · collected 2026-10-07 · by The Straits Times

Quick Summary

On October 7, the World Health Organization released guidelines recommending lifestyle changes such as diet and exercise over weight-loss drugs like GLP-1 for treating child obesity. The guidelines emphasize that medication and surgery should only be considered after non-drug interventions have failed, especially noting insufficient safety data for children under 10. With about 400 million people aged 5 to 19 being overweight in 2024, including 170 million with obesity, the organization underscores the importance of comprehensive support for healthy living and sustainable behavior change.
Written by AI on 2026-10-07, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

On October 7, WHO released its first global guidelines addressing rising childhood obesity rates. According to UNICEF, obesity now surpasses being underweight as the most common form of malnutrition among school-aged children and adolescents worldwide. The WHO recommends comprehensive support focusing on healthy eating, physical activity, and sustainable behavior change rather than relying solely on medical interventions like weight-loss drugs such as Saxenda or bariatric surgery.

For adolescents aged 10 to 19, the guidelines suggest considering GLP-1 drugs only after supervised lifestyle interventions have failed. For those with severe obesity who are physically and mentally mature, bariatric surgery can be considered if six months of ineffective treatment has been documented. However, for children under 10 years old, diet, physical activity, and behavioral support are endorsed instead due to safety concerns regarding medications and surgical options.

Luz María De Regil, director of the Department of Nutrition and Food Safety at WHO, emphasized that current evidence is insufficient on GLP-1 drugs but noted ongoing research could lead to revised recommendations.

Written for “WHO Guidance On Child ObesityTreatment” on 2026-11-03, grounded in this article and the 1 other(s) covering the same event.

Story

📰 WHO Guidance On Child ObesityTreatment
Health · 2 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads leans left and hedges 33% of its claims. Each row says how that neighbour differs.
CBC News
Hedges 4 of 34 claims Outlet record 74/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
15
sentences that state something as happening or true
Uncertain
33%
5 of 15 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
66/100
The Straits Times's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-07 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Straits Times · 4241 article(s) · 5 correction(s) detected
Running correction rate · 5 correction(s)

Who wrote this

The Straits Times
2766 article(s) here · 1 carrying a prediction
🔮 A US judge on Nov 2 temporarily barred the Trump administration from moving ahead with a plan it says would prevent non-citizen voting, but that critics say risks disenfranchising eligible voters and infringing on states’ authority over elections.
🔮 A US judge on Nov 2 temporarily barred the Trump administration from moving ahead with a plan it says would prevent non-citizen voting, but that critics say risks disenfranchising eligible voters and infringing on states’ authority over elections.
🔮 Distance from main parties Israeli President Isaac Herzog will begin meeting this week with representatives of parties that won seats in the Oct 27 vote, to determine to which leader to give the first shot at forming a government.
🔮 “And that would happen throughout the world,” he said adding that the world had been his “support network”.
🔮 When will we know who’s won the US midterm elections?
2026-11-03 · assertive framing · When will we know who’s won the US midterm elections?
🔮 Trump will have other ideas AI generated
2026-11-03 · mixed framing · Donald the Lame Duck? Trump will have other ideas
🔮 Itamar Ben Gvir, the far-right Israeli firebrand who achieved international notoriety as part of the outgoing government, fell short of expectations that he would gain ground in the latest election.
🔮 Earlier on Nov 2, US President Donald Trump raised doubts about whether he would follow through on a threatened resumption of military strikes against Iran and said a deal with Tehran could happen.
🔮 Investors nonetheless took his remarks as a sign that a fresh round of fighting between Tehran and Washington could be averted through diplomacy.
🔮 Now some of the local authorities have said they also fear that the President’s offer of a large financial incentive could foster unrest or even vigilantism, with Americans eyeing one another with suspicion as they head to the polls.
Also by The Straits Times
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 2766 articles by The Straits Times →

Topics

Saxenda The World Health Organization UNICEF WHO the Department of Nutrition and Food Safety

Subjects

WHO ORG · 5× De Regil ORG · 1× Luz María De Regil PERSON · 1× Novo Nordisk's ORG · 1× REUTERS ORG · 1× The World Health Organization ORG · 1× UNICEF ORG · 1× the Department of Nutrition and Food Safety ORG · 1× the European Union GPE · 1× the United States GPE · 1×

Narrative

"The foundation of obesity care for children and adolescents is not medicine or surgery, but access to comprehensive support that enables healthy eating, physical activity and sustainable behaviour change," De Regil said.
framing: mixed · carried by 1 article(s) · first seen 2026-10-07
🔮 The health agency said weight-loss drugs may be considered for adolescents aged 10 to 19 with obesity but only after supervised interventions have failed.
2026-10-07 · The Straits Times
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight · mixed framing

Claims (15 extracted, 5 hedged)

WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Oct 7 - asserted
WHO → endorse → fight
The World Health Organization on Wednesday recommended diet, exercise and counseling over popular weight-loss drugs in its first global guidelines addressing rising obesity among younger children. asserted
Organization → recommend → children
According to UNICEF data, obesity has surpassed being underweight as the most common form of malnutrition in school children and adolescents worldwide. uncertain
obesity → accord → children
The health agency said weight-loss drugs may be considered for adolescents aged 10 to 19 with obesity but only after supervised interventions have failed. uncertain
interventions → say → obesity
Bariatric surgery could be considered for physically and mentally mature adolescents with severe obesity after six months of unsuccessful treatment, it said. uncertain
it → consider → treatment
For children under 10, WHO endorsed diet, physical activity and combined behavioral support instead of obesity medication, surgery or devices because of doubts over their safety and long-term effectiveness. asserted
WHO → endorse → safety
Luz María De Regil, director of the Department of Nutrition and Food Safety, said there is currently insufficient evidence on GLP-1 drugs, though researchers are monitoring efficacy and safety trials and may revise that assessment as more data emerges. uncertain
data → say → assessment
"The foundation of obesity care for children and adolescents is not medicine or surgery, but access to comprehensive support that enables healthy eating, physical activity and sustainable behaviour change," De Regil said. asserted
Regil → enable → eating
Some GLP-1 medicines are already approved for weight-loss in younger patients. asserted
medicines → approve → patients
Novo Nordisk's Wegovy and Saxenda can be used by certain adolescents 12 and older in the United States and the European Union. asserted
Wegovy → use → States
The EU also allows Saxenda for some children aged six to 11. asserted
EU → allow → children
For children and adolescents with obesity, WHO strongly suggested tailored diets, physical activity and behavioral programs involving caregivers, with supervised digital support cited as optional. uncertain
support → suggest → caregivers
Healthy diets and physical activity must also be accessible and affordable because treatment alone cannot halt rising obesity, WHO said. asserted
WHO → halt → obesity
About 400 million people aged 5 to 19 were overweight in 2024, including 170 million living with obesity, WHO said. asserted
WHO → age → obesity
Obesity prevalence in the group has quadrupled since 1990. asserted
prevalence → quadruple → 1990
💬Give feedback
🕘History 🎫Support